Noven Gains Phase III Vasomotor Symptoms Candidate With JDS Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Miami firm predicts four potential new product launches in four years based on specialty pharma JDS’ pipeline.
You may also be interested in...
Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line
“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.
Nutrition 21 Revives Under Leadership Of Former Pharma Exec Satow
Michael Satow, formerly of JDS Pharmaceuticals, tries his hand in the nutritional ingredients space as CEO of Nutrition 21. In a recent interview, Satow discussed his initial impressions of the industry and what potential he sees in a portfolio that includes Chromax chromium picolinate.
Nutrition 21 Revives Under Leadership Of Former Pharma Exec Satow
Michael Satow, formerly of JDS Pharmaceuticals, tries his hand in the nutritional ingredients space as CEO of Nutrition 21. In a recent interview, Satow discussed his initial impressions of the industry and what potential he sees in a portfolio that includes Chromax chromium picolinate.